{"id":4867,"date":"2019-05-14T10:21:25","date_gmt":"2019-05-14T09:21:25","guid":{"rendered":"http:\/\/medicine.st-andrews.ac.uk\/?p=4867"},"modified":"2019-05-14T10:21:25","modified_gmt":"2019-05-14T09:21:25","slug":"visit-from-dr-sekaggya-wiltshire","status":"publish","type":"post","link":"https:\/\/medicine.st-andrews.ac.uk\/news\/visit-from-dr-sekaggya-wiltshire\/","title":{"rendered":"Visit from Dr Sekaggya-Wiltshire"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-4868 aligncenter\" src=\"http:\/\/med.st-andrews.ac.uk\/medicine\/wp-content\/uploads\/sites\/28\/2019\/05\/IMG_0847-300x169.png\" alt=\"\" width=\"300\" height=\"169\" \/><\/p>\n<p>&nbsp;<\/p>\n<p>The Infection and Global Health Division recently welcome Dr Christine Sekaggya-Wiltshire from the Infectious Diseases Unit, Makarere University, Kampala, Uganda who delivered a talk on &#8216;A Collaborative Effort to Determine the Safety and Efficacy of High Dose Rifampicin in a Tuberculosis-HIV co-infected population&#8217;.<\/p>\n<p>Dr Sekaggya-Wiltshire is a prominent female African clinician scientist, and was recently profiled in The Lancet after winning the Steve Lawn TB-HIV Research Leadership Prize. Whilst in the UK Dr Sekaggya-Wiltshire met with colleagues both in St Andrews and Edinburgh. Dr Sekaggya-Wiltshire is pictured on the right of the image above along with her colleague Dr Olive Mbabazi (centre) and members of the Infection and Global Health Division.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Infection and Global Health Division recently welcome Dr Christine Sekaggya-Wiltshire and Dr Olive Mbabazi from Makarere University.<\/p>\n","protected":false},"author":39,"featured_media":4868,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[10,1],"tags":[302,369,573,606,1095,1130,1134],"class_list":["post-4867","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-uncategorised","tag-dr-christine-sekaggya-wiltshire","tag-dr-olive-mbabazi","tag-high-dose-rifampicin","tag-infection-and-global-health-division","tag-tb","tag-tuberculosis","tag-uganda"],"publishpress_future_action":{"enabled":false,"date":"2026-05-08 10:35:37","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/posts\/4867","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/comments?post=4867"}],"version-history":[{"count":0,"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/posts\/4867\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/media\/4868"}],"wp:attachment":[{"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/media?parent=4867"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/categories?post=4867"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/tags?post=4867"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}